Follow The Filings

XENE Xenon Pharmaceuticals

Xenon Pharmaceuticals earnings company data as of 11:01 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 2 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by XENE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All XENE insider trades
  • $1.7M bought by 2 insiders
  • $641K sold by 1 insider outside a trading plan
  • $19.6M sold by 2 insiders under 10b5-1 plans
  1. Thomas Patrick Kelly CFO
    Buy
    $560K 15,000 shares at $37.32 New stake
    Traded Sep 30 Filed Oct 1
    ↗
  2. Ian Mortimer CEO
    Buy
    $1.1M 30,000 shares at $37.38 +151% to stake
    Traded Sep 30 Filed Oct 1
    ↗
  3. Christopher John Kenney Chief Medical Officer
    Planned sale
    $426K 7,068 shares at $60.25 100% of stake
    Traded Aug 28 Filed Aug 31
    ↗
  4. Steven Gannon Director
    Sale
    $641K 10,000 shares at $64.06 84% of stake
    Traded Aug 11 Filed Aug 13
    ↗
  5. Ian Mortimer CEO
    Planned sale
    $16.3M 270,000 shares at $60.33 98% of stake
    Traded Mar 9 Filed Mar 11
    ↗
  6. Ian Mortimer CEO
    Planned sale
    $1.8M 40,000 shares at $44.43 87% of stake
    Traded Jan 2 Filed Jan 2
    ↗
  7. Ian Mortimer CEO
    Planned sale
    $1.1M 25,205 shares at $45.33 81% of stake
    Traded Dec 5–8 Filed Dec 9, 2025
    ↗
  8. Ian Mortimer CEO
    Planned sale
    $4,366 97 shares at $45.01 0.3% of stake
    Traded Nov 28, 2025 Filed Dec 3, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 21 option exercises, 8 sales to cover taxes, and 2 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
424B5 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.